City

Bethesda (2)

Chandigarh (1)

Condition

Immune Modulation (3)

Healthy Volunteers (1)

Leprosy (1)

Lyme Disease (1)

Pertussis (1)

Septic Shock (1)

Severe Sepsis (1)

Statins (1)

Tuberculosis (1)

Overall Status

Completed (2)

Terminated (1)

Sign in for free

Phase

phase 2/phase 3 (1)

Sponsor

National Heart, Lung, and Blood Institute (NHLBI) (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Postgraduate Institute of Medical Education and Research (1)

Collaborator

Intervention

mw, 0.3ml x three days sc (1)

placebo (1)

Study Documents

Intervention Type

drug (1)

Funder Type

NIH (2)

Other (1)

Study Type

Observational (2)

Interventional (1)

immune modulation

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

CD8 Reactivity to Microorganisms in Blood and Breast Milk

Terminated

Immune Modulation
+4 more

Bethesda, Maryland

National Institutes of Health Clinical Center

Nov 13, 2019

Rosuvastatin on the Immune System in Healthy Normal Cholesterol

Completed

Healthy Volunteers
+2 more

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Oct 5, 2018

Severe Sepsis, Septic Shock, Immune Modulation Trial in Chandigarh (Mw, 0.3ml x three days sc, Placebo)

Completed

Severe Sepsis
+2 more

Mw, 0.3ml x three days sc
Placebo

Chandigarh, India

PIMER

Mar 19, 2014